Pendal Group’s AbbVie ABBV Stock Holding History

Pendal Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,534	Closed	-$695K	–	448
2022 Q2	$695K	Buy	4,534 +2,701	+147%	+$413K	0.01%	308
2022 Q1	$297K	Sell	1,833 -502	-21%	-$72.9K	﹤0.01%	448
2021 Q4	$316K	Buy	+2,335	New	+$276K	﹤0.01%	500
2021 Q2	–	Sell	-16,404	Closed	-$1.77M	–	548
2021 Q1	$1.77M	Buy	16,404 +3,854	+31%	+$412K	0.02%	238
2020 Q4	$1.34M	Sell	12,550 -20,625	-62%	-$1.98M	0.01%	256
2020 Q3	$2.91M	Sell	33,175 -56,134	-63%	-$5.28M	0.04%	140
2020 Q2	$8.77M	Buy	89,309 +81,879	+1,102%	+$7.21M	0.12%	78
2020 Q1	$566K	Buy	+7,430	New	+$633K	0.01%	261
2019 Q3	–	Sell	-81,903	Closed	-$5.96M	–	447
2019 Q2	$5.96M	Sell	81,903 -62,874	-43%	-$4.94M	0.08%	115
2019 Q1	$11.7M	Buy	144,777 +131,278	+973%	+$10.7M	0.16%	78
2018 Q4	$1.24M	Sell	13,499 -34,207	-72%	-$3.01M	0.02%	250
2018 Q3	$4.51M	Sell	47,706 -27,135	-36%	-$2.57M	0.06%	143
2018 Q2	$6.93M	Sell	74,841 -19,722	-21%	-$1.93M	0.09%	139
2018 Q1	$8.95M	Buy	94,563 +1,036	+1%	+$114K	0.12%	124
2017 Q4	$9.04M	Sell	93,527 -23,621	-20%	-$2.23M	0.12%	128
2017 Q3	$10.5M	Buy	+117,148	New	+$8.92M	0.14%	121

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Pendal Group's ABBV Position: Q3 2022 in Review

Pendal Group sold out of AbbVie (ABBV) in Q3 2022, closing a stake of 4,534 shares — an estimated $695K sold.

Pendal Group first reported a position in ABBV in Q3 2017 and held it in 16 quarters. The position peaked at $11.7M in Q1 2019. 2,969 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.

Pendal Group reported no remaining AbbVie position as of Q3 2022 after selling out during the quarter.
Pendal Group sold 4,534 AbbVie shares in Q3 2022, an estimated $695K.
Pendal Group first reported a position in AbbVie in Q3 2017 and held it in 16 quarters.
Pendal Group's AbbVie position peaked at $11.7M in Q1 2019.
2,969 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.

Based on Pendal Group's 13F filing for Q3 2022, filed 18 Oct 2022.